Comparative Safety Surveillance of Triple (IDA) Versus Dual Therapy (DA) in Mass Drug Administration for Elimination of Lymphatic Filariasis in Kenya: A Cohort Event Monitoring Study

被引：0
|
作者：
Christabel Khaemba
Abbie Barry
Wyckliff P. Omondi
Elvis Kirui
Margaret Oluka
Gurumurthy Parthasarathi
Sammy M. Njenga
Anastacia Guantai
Eleni Aklillu
机构：
[1] Karolinska Institutet,Department of Global Public Health
[2] Pharmacy and Poisons Board,Department of Pharmacology and Pharmacognosy, School of Pharmacy
[3] Ministry of Health,Pharmacovigilance and Clinical Trials
[4] National Neglected Tropical Diseases Program,undefined
[5] Ministry of Health,undefined
[6] National Public Health Laboratory,undefined
[7] University of Nairobi,undefined
[8] Botswana Medicines Regulatory Authority,undefined
[9] Kenya Medical Research Institute (KEMRI),undefined
来源：
Drug Safety | 2023年 / 46卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：961 / 974
页数：13
相关论文
共 11 条
  • [1] Comparative Safety Surveillance of Triple (IDA) Versus Dual Therapy (DA) in Mass Drug Administration for Elimination of Lymphatic Filariasis in Kenya: A Cohort Event Monitoring Study
    Khaemba, Christabel
    Barry, Abbie
    Omondi, Wyckliff P.
    Kirui, Elvis
    Oluka, Margaret
    Parthasarathi, Gurumurthy
    Njenga, Sammy M.
    Guantai, Anastacia
    Aklillu, Eleni
    [J]. DRUG SAFETY, 2023, 46 (10) : 961 - 974
  • [2] Safety and Tolerability of Mass Diethylcarbamazine and Albendazole Administration for the Elimination of Lymphatic Filariasis in Kenya: An Active Surveillance Study
    Khaemba, Christabel
    Barry, Abbie
    Omondi, Wyckliff P.
    Bota, Kefa
    Matendechero, Sultani
    Wandera, Cecilia
    Siyoi, Fred
    Kirui, Elvis
    Oluka, Margaret
    Nambwa, Pamela
    Gurumurthy, Parthasarathi
    Njenga, Sammy M.
    Guantai, Anastacia
    Aklillu, Eleni
    [J]. PHARMACEUTICALS, 2021, 14 (03)
  • [3] A MULTICENTER STUDY OF THE SAFETY OF TRIPLE DRUG MASS DRUG ADMINISTRATION FOR LYMPHATIC FILARIASIS
    Weil, Gary J.
    Bogus, Joshua
    Dubray, Christine
    Fischer, Peter U.
    Jambulingam, P.
    King, Christopher L.
    Lemoine, Jean Frantz
    O'Brian, Katiuscia
    Robinson, Leanne J.
    Supali, Taniawati
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05): : 239 - 239
  • [4] Safety and Tolerability of Ivermectin and Albendazole Mass Drug Administration in Lymphatic Filariasis Endemic Communities of Tanzania: A Cohort Event Monitoring Study
    Fimbo, Adam M.
    Minzi, Omary Mashiku
    Mmbando, Bruno P.
    Gurumurthy, Parthasarathi
    Kamuhabwa, Appolinary A. R.
    Aklillu, Eleni
    [J]. PHARMACEUTICALS, 2022, 15 (05)
  • [5] THE RELATIVE SAFETY OF A PROMISING TRIPLE DRUG MASS DRUG ADMINISTRATION REGIMEN VERSUS A TWO-DRUG REGIMEN FOR LYMPHATIC FILARIASIS ELIMINATION IN INDIA
    Purushothaman, Jambulingam
    Kuttiatt, Vijesh
    Swaminathan, Subramanian
    Kaliannagounder, Krishnamoorthy
    Adinarayanan, Srividya
    Weil, Gary
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2018, 99 (04): : 614 - 614
  • [6] Socioeconomic factors associated with compliance with mass drug administration for lymphatic filariasis elimination in Kenya: Descriptive study results
    Njomo, Doris W.
    Amuyunzu-Nyamongo, M.
    Mukoko, Dunstan A.
    Magambo, Japheth K.
    Njenga, Sammy M.
    [J]. ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2012, 5 (02) : 103 - 110
  • [7] Increasing Coverage in Mass Drug Administration for Lymphatic Filariasis Elimination in an Urban Setting: a Study of Malindi Town, Kenya
    Njomo, Doris W.
    Mukoko, Dunstan A.
    Nyamongo, Nipher K.
    Karanja, Joan
    [J]. PLOS ONE, 2014, 9 (01):
  • [8] Towards elimination of Lymphatic Filariasis in Kenya: improving advocacy, communication and social mobilization activities for mass drug administration, a qualitative study
    Kibe, Lydiah W.
    Kimani, Bridget W.
    Okoyo, Collins
    Omondi, Wyckliff P.
    Sultani, Hadley M.
    Njomo, Doris W.
    [J]. TROPICAL DISEASES TRAVEL MEDICINE AND VACCINES, 2022, 8 (01)
  • [9] Towards elimination of Lymphatic Filariasis in Kenya: improving advocacy, communication and social mobilization activities for mass drug administration, a qualitative study
    Lydiah W. Kibe
    Bridget W. Kimani
    Collins Okoyo
    Wyckliff P. Omondi
    Hadley M. Sultani
    Doris W. Njomo
    [J]. Tropical Diseases, Travel Medicine and Vaccines, 8
  • [10] The safety of double- and triple-drug community mass drug administration for lymphatic filariasis: A multicenter, open-label, cluster-randomized study
    Weil, Gary J.
    Bogus, Joshua
    Christian, Michael
    Dubray, Christine
    Djuardi, Yenny
    Fischer, Peter U.
    Goss, Charles W.
    Hardy, Myra
    Jambulingam, Purushothaman
    King, Christopher L.
    Kuttiat, Vijesh Sridhar
    Krishnamoorthy, Kaliannagounder
    Laman, Moses
    Lemoine, Jean Frantz
    O'Brian, Katiuscia K.
    Robinson, Leanne J.
    Samuela, Josaia
    Schechtman, Kenneth B.
    Sircar, Anita
    Srividya, Adinarayanan
    Steer, Andrew C.
    Supali, Taniawati
    Subramanian, Swaminathan
    Pomat, William
    Tavul, Livingstone
    Kotty, Bethuel
    Howard, Samuel Cade
    Maure, Tobias
    Kerry, Zebedee
    Samuel, Anna
    Kumai, Steven
    Makita, Leo
    John, Lucy
    Bieb, Sibauk
    Rahi, Manju
    Basker, Nandha
    Raju, Hari Kishan K.
    Britto, R. L. J.
    Somani, Roopali
    Dwivedi, Gangeshwar Prasad
    Dr Suryaprakash
    Gaded, Shravanappa
    Lefevre, Regine
    Thys, France
    Jasmin, Robert
    Fayette, Carl
    Javell, Alain
    Ernest, Jean Romuald
    Pavilus, Guy
    Dereny, Abdel
    [J]. PLOS MEDICINE, 2019, 16 (06)
12